{
    "2020-06-29": [
        [
            {
                "time": "2020-06-29",
                "original_text": "新冠mRNA疫苗获批临床！沃森生物高开回落，为何遭趁机减持？ 减持股份",
                "features": {
                    "keywords": [
                        "mRNA疫苗",
                        "获批临床",
                        "沃森生物",
                        "高开回落",
                        "减持"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "医药行业周报：第三轮全国集采脚步临近 持续关注原料药制剂一体化公司",
                "features": {
                    "keywords": [
                        "医药行业",
                        "全国集采",
                        "原料药制剂一体化"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "国内首个新冠mRNA疫苗获批临床 沃森生物牵手艾博生物验证中国速度",
                "features": {
                    "keywords": [
                        "新冠mRNA疫苗",
                        "获批临床",
                        "沃森生物",
                        "艾博生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "杠杆资金超百亿涌入医药股 重仓“伏击”华北制药、国药股份等",
                "features": {
                    "keywords": [
                        "杠杆资金",
                        "医药股",
                        "华北制药",
                        "国药股份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "欧林生物连续亏损冲科创板 控股股东持股比例较低 亏损",
                "features": {
                    "keywords": [
                        "欧林生物",
                        "连续亏损",
                        "科创板"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "31股获机构买入型评级 沃森生物等3股关注度最高",
                "features": {
                    "keywords": [
                        "机构买入评级",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "首席观点 | 监管层出手规范行业经营，助力资本市场行稳致远",
                "features": {
                    "keywords": [
                        "监管层",
                        "规范行业经营",
                        "资本市场"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "31股今日获机构买入评级8股上涨空间超20%",
                "features": {
                    "keywords": [
                        "机构买入评级",
                        "上涨空间"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "18股获买入评级 最新:溢 多 利",
                "features": {
                    "keywords": [
                        "买入评级",
                        "溢多利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "A股早报2020年6月29日星期一",
                "features": {
                    "keywords": [
                        "A股早报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "沃森生物(300142)公司点评：mRNA新冠疫苗获批临床 研发管线全力推进",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA新冠疫苗",
                        "获批临床",
                        "研发管线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "【中证盘前】商业银行将获券商牌照？证监会回应；精选层本周“打新”；沃森生物新冠疫苗临床试验；黄光裕获假释；道指暴跌730点",
                "features": {
                    "keywords": [
                        "商业银行",
                        "券商牌照",
                        "证监会",
                        "精选层",
                        "沃森生物",
                        "新冠疫苗",
                        "道指暴跌"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}